MDMA therapy for PTSD rejected by FDA panel
5 June 2024Nature, Published online: 05 June 2024; doi:10.1038/d41586-024-01622-3
Scientific advisers vote overwhelmingly that the risks of MDMA treatment for post-traumatic stress disorder outweigh the benefits.